Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

CUSIP: 05156V102

Q1 2018 13F Holders as of 31 Mar 2018

Holder snapshot 7 signals
Share change
-2,138,984
Put/Call ratio
469%
SEC-reported price per share
$5.19
Number of holders
63
Value change
-$10,024,771
Number of buys
27
Open additional details 1 more signal available
Number of sells
28
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
130,441,060

Security key

05156V102

Report period

Q1 2018

Institutions

63

Top holders

10

Ownership snapshot

Top reported holders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
NEA Management Company, LLC
Disclosed value leader
NEA Management Company, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2017
13F Lead comparable stake: 3.7% Showing 1-6 of 15 holder rows.

Quick read

NEA Management Company, LLC leads the comparable SEC ownership view at 3.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens NEA Management Company, LLC's linked filing trail.
Comparable ownership Top 5
NEA Management Company, LLC 3.7%
FMR LLC 3.7%
Polar Capital LLP 1.8%
ORBIMED ADVISORS LLC 1.4%
FRANKLIN RESOURCES INC 1.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
NEA Management Company, LLC
13F
Company
13F
3.7%
$21,782,000
4,808,483 shares
31 Dec 2017
FMR LLC
13F
Company
13F
3.7%
$21,764,000
4,804,481 shares
31 Dec 2017
Polar Capital LLP
13F
Company
13F
1.8%
$10,419,000
2,300,000 shares
31 Dec 2017
ORBIMED ADVISORS LLC
13F
Company
13F
1.4%
$8,142,000
1,797,400 shares
31 Dec 2017
FRANKLIN RESOURCES INC
13F
Company
13F
1.3%
$7,540,000
1,664,400 shares
31 Dec 2017
Vivo Capital, LLC
13F
Company
13F
0.93%
$5,496,000
1,213,290 shares
31 Dec 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
63
Shares
21,720,891
Rows available
63
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
66
Q1 2018 holders
63
Holder diff
-3
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 value Q1 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .